← Back to headlines
Johnson & Johnson to Invest $1 Billion in New CGT Manufacturing Site in Pennsylvania
Johnson & Johnson plans to construct a new $1 billion cell and gene therapy manufacturing facility in Pennsylvania, expanding its production capabilities.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
